The Food and Drug Administration has approved bemotrizinol as a new active ingredient for sunscreen, marking the first addition to the list of approved sun-protecting options in decades. Department of Health and Human Services Secretary Robert F. Kennedy Jr. called the approval a win for the Make America Healthy Again movement, pointing to bemotrizinol's long-standing use in Europe, where it has been available for decades under stricter consumer protection frameworks.
Until this approval, only two sun-protecting agents had sufficient data for FDA recognition as safe, with other approved ingredients existing in what health advocates describe as a regulatory gray area. The development comes after several major drugstore sunscreen lines were pulled from shelves in 2021 due to carcinogen contamination, prompting consumer concern about product safety.
What the Right Is Saying
Secretary Kennedy and MAHA supporters argue that the FDA's slow approval process has denied Americans access to safer, more effective sunscreen options for years. They point to Europe, which currently approves more than double the number of active sunscreen ingredients as the United States, as evidence that American consumers have been unnecessarily restricted from products with strong safety track records.
Senator Ron Johnson of Wisconsin has been among those calling for regulatory reform at the FDA, arguing that bureaucratic inertia has prioritized process over public health outcomes. Conservative commentators note that bemotrizinol's European approval history spanning decades provides substantial real-world safety data that should have accelerated American availability.
Free-market advocates argue that adults should have the freedom to choose products based on their own risk assessments and family health priorities. The Heritage Foundation has previously argued for regulatory frameworks that allow consumers greater agency in personal health decisions, contending that one-size-fits-all federal mandates often fail to account for individual circumstances and preferences.
What the Left Is Saying
Progressive health advocates have long called for stronger FDA oversight of cosmetic and personal care products, arguing that the current approval process leaves consumers vulnerable. Environmental justice groups note that skin cancer rates vary significantly by demographic group, with certain communities facing disproportionate exposure risks due to occupational factors and limited access to preventive healthcare.
Consumer safety organizations aligned with Democratic priorities have pushed for more rigorous pre-market testing requirements. Representative Jan Schakowsky of Illinois, who has championed consumer protection legislation, has previously stated that Americans deserve certainty about the products they use on their bodies, particularly when those products are used by children and pregnant women.
Dermatologists affiliated with academic medical centers note that regardless of ingredient type, consistent application of SPF 30 or higher every two hours remains the gold standard for sun protection. The American Academy of Dermatology has maintained that mineral-based sunscreens containing zinc oxide or titanium dioxide offer effective broad-spectrum protection without the skin absorption concerns associated with chemical filters.
What the Numbers Show
Europe currently approves more than twice as many active sunscreen ingredients as the United States. Prior to bemotrizinol's approval, only two ingredients — zinc oxide and titanium dioxide in mineral formulations — had received FDA designation as Category I (safe and effective) status based on sufficient safety data.
The 2021 recall of major drugstore sunscreen lines due to benzene contamination affected products from multiple manufacturers. Benzene is classified as a known human carcinogen by the Environmental Protection Agency, with no acceptable level for cosmetic products according to FDA guidance.
Dermatologists recommend SPF 30 or higher applied every two hours for adequate protection. Research published in JAMA Dermatology found that most users apply only 25-50% of the recommended amount, significantly reducing effective protection regardless of ingredient formulation.
The Skin Cancer Foundation reports that one in five Americans will develop skin cancer by age 70. UVB radiation is primarily associated with sunburn and certain skin cancers, while UVA rays penetrate deeper, contributing to both skin aging and DNA damage linked to cancer development.
The Bottom Line
The FDA's approval of bemotrizinol represents a significant shift in the regulatory landscape for sun protection products, potentially expanding consumer options for safer formulations. However, industry analysts note it will take time for new products containing the ingredient to reach retail shelves, with summer availability unlikely this year.
For parents seeking immediate options, mineral-based sunscreens using zinc oxide remain the only FDA-designated Category I active ingredients currently available in standard formulations. These products work by sitting on the skin's surface rather than being absorbed, addressing concerns about systemic chemical exposure raised by health advocates.
The broader debate reflects ongoing tensions between regulatory caution and consumer access. Questions about how quickly manufacturers will bring bemotrizinol-based products to market, at what price points, and whether insurance coverage might eventually extend to prescription sun protection formulations will likely shape the policy discussion in coming months.